Paul Thomas - Concepedia

Author

Paul Thomas

Royal Brisbane and Women's Hospital ORCID

Also Known As

Min You, P A THOMAS, P A Thomas, P THOMAS, P Thomas, P. A. THOMAS, P. A. Thomas, P. A. V. Thomas, P. Thomas, P.A. Thomas

244

Publications

7.5K

Citations

H-Index

132

Concepts

All Affiliations

Royal Brisbane and Women's Hospital The University of Queensland Princess Alexandra Hospital QIMR Berghofer Medical Research Institute University of Newcastle Australia

About

Paul Thomas is an author at Royal Brisbane and Women's Hospital specializing in medicine, radiology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	46	5.1K
2	Health Sciences	13	14	2.7K
3	Engineering	3	3	67
4	Public Health	2	2	129
5	Natural Sciences	1	1	13

Paul Thomas

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, The Lancet UrologySurgical OncologyHigh-risk Prostate CancerGenitourinary CancerOncologic Imaging	2020	1.8K
Modern thirty-day operative mortality for surgical resections in lung cancer Robert J. Ginsberg, Lucius D. Hill, Robert T. Eagan, Journal of Thoracic and Cardiovascular Surgery Surgical OncologyMedicineBronchial NeoplasmThoracic SurgerySurgery	1983	654
Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial Richard J. McManus, Jonathan Mant, Marloes Franssen, The Lancet	2018	405
The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study Louise Emmett, James P Buteau, Nathan Papa, European Urology Additive Diagnostic ValueUrologyMedical ImagingCancer DetectionDiagnosis	2021	394
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial William W. Busse, Eugene R. Bleecker, J Mark FitzGerald, The Lancet Respiratory Medicine AsthmaRheumatologyExtension TrialAllergyAllergy Medicine	2018	298
Cancer recurrence after resection: T1 N0 non-small cell lung cancer Paul Thomas The Annals of Thoracic Surgery Surgical OncologyMedicineCancer RecurrencePathologyCancer Treatment	1990	227
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial Michael S. Hofman, Louise Emmett, Shahneen Sandhu, The Lancet Oncology UrologyOverall SurvivalGenitourinary CancerMedicineCancer Management	2023	172
The diagnosis of polycystic ovaries in women with oligo‐amenorrhoea: predictive power of endocrine tests Robert Fox, Elizabeth Corrigan, Paul Thomas, Clinical Endocrinology	1991	144
Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour Handoo Rhee, John Blazak, Chui Ming Tham, EJNMMI Research	2016	136
Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer Harrison K. Rhee, Paul Thomas, Benjamin Shepherd, The Journal of Urology	2016	129

Page 1